Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,367
Award facts
- Contract value 100% obligated
- $29,367.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29.4K delivery order to AmerSourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 23, 2026. The performance location is AmerSourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
AmerSourceBergen is a major pharmaceutical distributor providing critical medical products to federal agencies, particularly the Department of Defense and its healthcare systems. The parent company, Cencora, Inc., also holds a separate IDC with DLA Troop Support Medical valued at up to $999.9M through December 31, 2031, underscoring the company's significant role in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs globally. The award reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F9MN9?
SPE2DR26F9MN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MN9 worth?
The government has obligated $29,367 on SPE2DR26F9MN9.
Is contract SPE2DR26F9MN9 an order under another contract?
Yes. SPE2DR26F9MN9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MN9 competed?
The extent of competition for SPE2DR26F9MN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award